Home
About Us
Agenda
2023 Agenda
2022 Agenda
Speakers
Scientific Advisory Board
2023 Speakers
2022 Speakers
Partners
Commercial Partners 2023
Sponsorship Opportunities
Host a Webinar
Media Partners
Note to exhibitors
Summit Details
VENUE
Poster Competition
Contact Us
FAQs
Attendance
Why attend
Audience Breakdown
Ticket Details
2022 Attendees
Gallery
DDF Summits
DDF America
DDF Asia
Log in
Book Now
Leveraging New Therapeutic Modalities to expand the Druggable Target Space
3/9/2020
08:50 - 09:25
Innovation through new therapeutic modalities
Current landscape of oligonucleotide therapeutics, opportunities and the challenges
The promise of mRNA therapeutics and delivery hurdles
Future outlook
Please note that this will be a remote presentation
Shalini Andersson
, Chief Scientist New Therapeutic Modalities
, AstraZeneca
Back to programme
Shalini Andersson
Chief Scientist New Therapeutic Modalities
AstraZeneca
